IsaKRD Induction Achieves 95% Response Rate in Multiple Myeloma
New data reveals isatuximab-based therapy achieves high MRD-negativity rates in newly diagnosed multiple myeloma.
Evolving Strategies for RSV: Understanding Respiratory and Cardiovascular Impacts, Prevention, and Future Directions
Understanding RSV’s impact on both respiratory and cardiovascular health underscores the importance of holistic management, prevention through vaccination, and continued…
Humana’s CenterWell is acquiring The Villages Health in Florida
CenterWell, owned by Humana, is buying The Villages Health in Orlando, Florida, according to a notice from the healthcare provider…
Radiation or Immune-Modulating Drugs Could Mitigate Resistance to CDK4/6 Inhibitors in Breast Cancer
Research reveals that combining radiotherapy or immune-modulating drugs with CDK4/6 inhibitors enhances treatment efficacy in HR+/HER2– breast cancer.
Study Assesses Weight Reduction and Glycemic Status With GLP-1 Medications
Real-world studies reveal GLP-1 medications like semaglutide and tirzepatide yield less weight loss than clinical trials, highlighting treatment discontinuation challenges.
Mucosal EV Adjuvants May Revolutionize Intranasal Flu Vaccines
New research reveals that extracellular vesicles enhance intranasal flu vaccines, boosting mucosal immunity and offering broader protection against diverse strains.
Guiding Patients Through Allergy Medication Safety: Pharmacists’ Role Following FDA Warning on Cetirizine and Levocetirizine
The FDA is warning of rare severe itching after stopping long-term use of popular allergy medications cetirizine and levocetirizine, urging…
Redefining Pharmacovigilance Through Digital Innovation
AI is revolutionizing pharmacovigilance by enhancing data analysis, improving patient safety, and enabling proactive risk management in drug monitoring.
Infliximab Biosimilar Initiation Has Increased in Pediatric IBD, Study Finds
The study found biosimilar initiation rose to nearly 42% from 2016 to 2023.
Physician group, cities sue CMS over ACA final rule
Doctors for America; the cities of Baltimore, Chicago and Columbus, Ohio; and small business advocacy group Main Street Alliance are suing Robert F.…